AGTC logo

Applied Genetic Technologies (AGTC) CAPEX

Annual CAPEX

$2.01 M
+$153.00 K+8.22%

30 June 2022

3-Year Change

+8.22%
AGTC annual capital expenditures is up +8.22% over the past 3 years

All-time High

$2.59 M
AGTC annual capital expenditures is currently -22.30% below its historical high of $2.59 million
Annual FCF-$67.76 M
AGTC annual free cash flow is -$67.76 million
Annual CFO-$65.75 M
AGTC annual cash flow from operations is -$65.75 million
Annual CFI-$14.00 K
AGTC annual cash flow from investing activities is -$14.00 thousand
Annual CFF$7.08 M
AGTC annual cash flow from financing activities is $7.08 million

AGTC CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

N/A

30 September 2022

All-time High

$2.15 M
AGTC quarterly capital expenditures is currently at an all-time high
Quarterly FCF-$16.34 M
AGTC quarterly free cash flow is -$16.34 million
Quarterly CFO-$16.04 M
AGTC quarterly cash flow from operations is -$16.04 million
Quarterly CFI-$304.00 K
AGTC quarterly cash flow from investing activities is -$304.00 thousand
Quarterly CFF$7.14 M
AGTC quarterly cash flow from financing activities is $7.14 million

AGTC Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

N/A

30 September 2022

All-time High

$3.06 M
AGTC TTM capital expenditures is currently at an all-time high
TTM FCF-$67.55 M
AGTC TTM free cash flow is -$67.55 million
TTM CFO-$65.85 M
AGTC TTM cash flow from operations is -$65.85 million
TTM CFI-$1.70 M
AGTC TTM cash flow from investing activities is -$1.70 million
TTM CFF$14.20 M
AGTC TTM cash flow from financing activities is $14.20 million

AGTC TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AGTC CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+8.2%--
5 y5 years+547.6%--

AGTC CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-22.3%

Applied Genetic Technologies CAPEX History

DateAnnualQuarterlyTTM
June 2022
$2.01 M(+8.2%)
$860.00 K(+325.7%)
$2.01 M(+21.0%)
Mar 2022
-
$202.00 K(-40.1%)
$1.67 M(-9.1%)
Dec 2021
-
$337.00 K(-45.2%)
$1.83 M(+6.8%)
Sept 2021
-
$615.00 K(+20.4%)
$1.72 M(-7.8%)
June 2021
$1.86 M(+55.5%)
$511.00 K(+38.5%)
$1.86 M(+34.3%)
Mar 2021
-
$369.00 K(+67.0%)
$1.39 M(-6.8%)
Dec 2020
-
$221.00 K(-70.9%)
$1.49 M(-6.8%)
Sept 2020
-
$760.00 K(+2011.1%)
$1.59 M(+33.2%)
June 2020
$1.20 M(+284.9%)
$36.00 K(-92.3%)
$1.20 M(-3.7%)
Mar 2020
-
$470.00 K(+42.9%)
$1.24 M(+45.7%)
Dec 2019
-
$329.00 K(-9.1%)
$853.00 K(+40.1%)
Sept 2019
-
$362.00 K(+341.5%)
$609.00 K(+95.8%)
June 2019
$311.00 K(-61.3%)
$82.00 K(+2.5%)
$311.00 K(-17.7%)
Mar 2019
-
$80.00 K(-5.9%)
$378.00 K(-53.8%)
Dec 2018
-
$85.00 K(+32.8%)
$818.00 K(+11.0%)
Sept 2018
-
$64.00 K(-57.0%)
$737.00 K(-8.2%)
June 2018
$803.00 K(-9.9%)
$149.00 K(-71.3%)
$803.00 K(-5.9%)
Mar 2018
-
$520.00 K(>+9900.0%)
$853.00 K(+130.5%)
Dec 2017
-
$4000.00(-96.9%)
$370.00 K(-61.1%)
Sept 2017
-
$130.00 K(-34.7%)
$951.00 K(+6.7%)
DateAnnualQuarterlyTTM
June 2017
$891.00 K(-65.6%)
$199.00 K(+437.8%)
$891.00 K(-5.2%)
Mar 2017
-
$37.00 K(-93.7%)
$940.00 K(-69.2%)
Dec 2016
-
$585.00 K(+735.7%)
$3.06 M(+17.2%)
Sept 2016
-
$70.00 K(-71.8%)
$2.61 M(+0.6%)
June 2016
$2.59 M(+702.5%)
$248.00 K(-88.5%)
$2.59 M(+9.2%)
Mar 2016
-
$2.15 M(+1483.1%)
$2.37 M(+757.0%)
Dec 2015
-
$136.00 K(+147.3%)
$277.00 K(-8.0%)
Sept 2015
-
$55.00 K(+83.3%)
$301.00 K(-6.8%)
June 2015
$323.00 K(-14.1%)
$30.00 K(-46.4%)
$323.00 K(-30.8%)
Mar 2015
-
$56.00 K(-65.0%)
$467.00 K(-1.1%)
Dec 2014
-
$160.00 K(+107.8%)
$472.00 K(+26.2%)
Sept 2014
-
$77.00 K(-55.7%)
$374.00 K(-0.5%)
June 2014
$376.00 K(-29.2%)
$174.00 K(+185.2%)
$376.00 K(+32.9%)
Mar 2014
-
$61.00 K(-1.6%)
$283.00 K(-19.6%)
Dec 2013
-
$62.00 K(-21.5%)
$352.00 K(-33.1%)
Sept 2013
-
$79.00 K(-2.5%)
$526.00 K(-0.9%)
June 2013
$531.00 K(+391.7%)
$81.00 K(-37.7%)
$531.00 K(+18.0%)
Mar 2013
-
$130.00 K(-44.9%)
$450.00 K(+40.6%)
Dec 2012
-
$236.00 K(+181.0%)
$320.00 K(+281.0%)
Sept 2012
-
$84.00 K
$84.00 K
June 2012
$108.00 K
-
-

FAQ

  • What is Applied Genetic Technologies annual capital expenditures?
  • What is the all time high annual CAPEX for Applied Genetic Technologies?
  • What is the all time high quarterly CAPEX for Applied Genetic Technologies?
  • What is the all time high TTM CAPEX for Applied Genetic Technologies?

What is Applied Genetic Technologies annual capital expenditures?

The current annual CAPEX of AGTC is $2.01 M

What is the all time high annual CAPEX for Applied Genetic Technologies?

Applied Genetic Technologies all-time high annual capital expenditures is $2.59 M

What is the all time high quarterly CAPEX for Applied Genetic Technologies?

Applied Genetic Technologies all-time high quarterly capital expenditures is $2.15 M

What is the all time high TTM CAPEX for Applied Genetic Technologies?

Applied Genetic Technologies all-time high TTM capital expenditures is $3.06 M